These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6526106)

  • 1. Electroretinogram and ocular toxicity.
    Hellner KA; Gauri KK
    Dev Ophthalmol; 1984; 9():213-8. PubMed ID: 6526106
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinically evident chloroquine toxicity undetected by multifocal electroretinogram.
    Burnett HK; Somani R
    Can J Ophthalmol; 2012 Oct; 47(5):e31-3. PubMed ID: 23036562
    [No Abstract]   [Full Text] [Related]  

  • 3. The utility of multifocal electroretinography in monitoring drug toxicity: deferoxamine retinopathy.
    Kertes PJ; Lee TK; Coupland SG
    Can J Ophthalmol; 2004 Oct; 39(6):656-61. PubMed ID: 15559652
    [No Abstract]   [Full Text] [Related]  

  • 4. The multifocal pattern electroretinogram in chloroquine retinopathy.
    Neubauer AS; Stiefelmeyer S; Berninger T; Arden GB; Rudolph G
    Ophthalmic Res; 2004; 36(2):106-13. PubMed ID: 15017107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
    Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
    Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
    Kellner U; Renner AB; Tillack H
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chloroquine retinopathy].
    François J; de Rouck A; Cambie E; de Laey JJ
    Ophthalmologica; 1972; 165(2):81-99. PubMed ID: 4539289
    [No Abstract]   [Full Text] [Related]  

  • 9. Multifocal ERG in chloroquine retinopathy: regional variance of retinal dysfunction.
    Kellner U; Kraus H; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):94-7. PubMed ID: 10664060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine retinopathy. Is fluorescein angiography necessary?
    Cruess AF; Schachat AP; Nicholl J; Augsburger JJ
    Ophthalmology; 1985 Aug; 92(8):1127-9. PubMed ID: 4047606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed progression of bull's eye maculopathy.
    Jain S; Jain NG
    BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28596207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Multifocal Electroretinography in the Assessment of Drug-Induced Retinopathy: A Review of the Literature.
    Dettoraki M; Moschos MM
    Ophthalmic Res; 2016; 56(4):169-177. PubMed ID: 27351191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acquired colour-vision-deficiencies caused by side-effects of pharmacotherapy (author's transl)].
    Jaeger W
    Klin Monbl Augenheilkd; 1977 Mar; 170(3):453-60. PubMed ID: 17031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed onset chloroquine retinopathy presenting 10 years after long-term usage of chloroquine.
    Kazi MS; Saurabh K; Rishi P; Rishi E
    Middle East Afr J Ophthalmol; 2013; 20(1):89-91. PubMed ID: 23580861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescein angiographic changes in acute toxic retinopathy associated with polypharmacy.
    Shaikh S; Shaikh N; Blumenkranz MS
    Retina; 2000; 20(6):685-8. PubMed ID: 11131433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Involvement of PAF (Platelet-Activating Factor) in chloroquine-induced retinopathy].
    Meyniel G; Doly M; Millerin M; Braquet P
    C R Acad Sci III; 1992; 314(2):61-5. PubMed ID: 1559183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of drugs on the retina.
    Cerasoli JR
    Int Ophthalmol Clin; 1971; 11(2):121-35. PubMed ID: 4948448
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chloroquine retinopathy. Peculiar behavior of the light sense].
    Stein R; Godel V; Nemet P
    Klin Monbl Augenheilkd; 1972 Aug; 161(2):183-91. PubMed ID: 4638561
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.
    Tzekov R
    Doc Ophthalmol; 2005 Jan; 110(1):111-20. PubMed ID: 16249962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity.
    Martínez-Costa L; Victoria Ibañez M; Murcia-Bello C; Epifanio I; Verdejo-Gimeno C; Beltrán-Catalán E; Marco-Ventura P
    Can J Ophthalmol; 2013 Oct; 48(5):400-5. PubMed ID: 24093187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.